Cargando…

Financial Implications of Avapritinib for Treatment of Unresectable Gastrointestinal Stromal Tumors in Patients With a PDGFRA Exon 18 Variant or After 3 Previous Therapies in a Hypothetical US Health Plan

IMPORTANCE: With the approval of avapritinib for adults with unresectable or metastatic gastrointestinal stromal tumors (GISTs) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 variant, including PDGFRA D842V variants, and National Comprehensive Cancer Network guideline rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Proudman, David, Miller, Aaron, Nellesen, Dave, Gomes, Aparna, Mankoski, Raymond, Norregaard, Chelsea, Sullivan, Erin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672518/
https://www.ncbi.nlm.nih.gov/pubmed/33201235
http://dx.doi.org/10.1001/jamanetworkopen.2020.25866